Schizophrenia, “Just the Facts” 5. Treatment and prevention Past, present, and future

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

2005 • 5,799 citations

Clozapine for the Treatment-Resistant Schizophrenic

1988 • 4,030 citations

What are the functional consequences of neurocognitive deficits in schizophrenia?

1996 • 3,505 citations

Dementia Praecox and Paraphrenia.

1972 • 3,028 citations

Antipsychotic-Induced Weight Gain: A Comprehensive Research Synthesis

1999 • 2,382 citations

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1976 • 2,224 citations

Remission in Schizophrenia: Proposed Criteria and Rationale for Consensus

2005 • 2,148 citations

Reducing Risks for Mental Disorders

1994 • 2,121 citations

The Cochrane Library

2005 • 2,069 citations

A Systematic Review of Mortality in Schizophrenia

2007 • 1,999 citations

Preventing Mental, Emotional, and Behavioral Disorders Among Young People: Progress and Possibilities

2009 • 1,868 citations

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

2008 • 1,842 citations

Influence of Family Life on the Course of Schizophrenic Disorders: A Replication

1972 • 1,769 citations

Antipsychotic drug doses and neuroleptic/dopamine receptors

1976 • 1,623 citations

Discovering the Neural Basis of Human Social Anxiety: A Diagnostic and Therapeutic Imperative

2004 • 1,429 citations

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

1997 • 1,357 citations

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

1989 • 1,313 citations

Deficit and nondeficit forms of schizophrenia: the concept

1988 • 1,307 citations

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

2009 • 1,305 citations

Clozapine Treatment for Suicidality in Schizophrenia<subtitle>International Suicide Prevention Trial (InterSePT)</subtitle>

2003 • 1,290 citations

Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis

2005 • 1,283 citations

Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states.

2006 • 1,267 citations

Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research

1995 • 1,186 citations

The NIMH-MATRICS Consensus Statement on Negative Symptoms

2006 • 1,180 citations

A Meta-Analysis of Cognitive Remediation in Schizophrenia

2007 • 1,175 citations

International Consensus Study of Antipsychotic Dosing

2010 • 1,175 citations

Randomized Controlled Trial of the Effect on Quality of Life of Second- vs First-Generation Antipsychotic Drugs in Schizophrenia

2006 • 1,117 citations

Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death

2009 • 1,099 citations

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

2000 • 1,079 citations

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

2008 • 1,049 citations

Randomized Controlled Trial of Interventions Designed to Reduce the Risk of Progression to First-Episode Psychosis in a Clinical Sample With Subthreshold Symptoms

2002 • 1,045 citations

Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial

2007 • 1,036 citations

Relationship Between Dopamine D₂ Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia

2000 • 1,036 citations

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial

2007 • 1,021 citations

A Meta-analysis of the Efficacy of Second-Generation Antipsychotics

2003 • 1,008 citations

Cognitive Behavior Therapy for Schizophrenia: Effect Sizes, Clinical Models, and Methodological Rigor

2007 • 994 citations

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

2004 • 948 citations

Schizophrenia, “just the facts” 4. Clinical features and conceptualization

2009 • 935 citations

Family Psychoeducation, Social Skills Training, and Maintenance Chemotherapy in the Aftercare Treatment of Schizophrenia

1986 • 925 citations

Psychological treatments in schizophrenia: I. Meta-analysis of family intervention and cognitive behaviour therapy

2002 • 902 citations

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

2009 • 892 citations

The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements

2009 • 886 citations

Duration of psychosis and outcome in first-episode schizophrenia

1992 • 878 citations

Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders

2010 • 871 citations

Schizophrenia and employment

2004 • 850 citations

Physical Health Monitoring of Patients With Schizophrenia

2004 • 830 citations

Antipsychotic Drugs: Prolonged QTc Interval, Torsade de Pointes, and Sudden Death

2001 • 824 citations

Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials

1999 • 807 citations

Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

2006 • 806 citations

Neuroleptics and the Natural Course of Schizophrenia

1991 • 777 citations

Early intervention in psychosis. The critical period hypothesis.

1998 • 741 citations

The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements

2009 • 737 citations

Family intervention for schizophrenia

2006 • 725 citations

Cognitive therapy for the prevention of psychosis in people at ultra-high risk

2004 • 723 citations

Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence

1998 • 719 citations

Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

2006 • 719 citations

Schizophrenia, “Just the Facts” What we know in 2008. 2. Epidemiology and etiology

2008 • 713 citations

The Effect of Family Interventions on Relapse and Rehospitalization in Schizophrenia--A Meta-analysis

2001 • 640 citations

National Institute of Mental Health Longitudinal Study of Chronic Schizophrenia

1991 • 639 citations

Effectiveness of Second-Generation Antipsychotics in Patients With Treatment-Resistant Schizophrenia: A Review and Meta-Analysis of Randomized Trials

2001 • 631 citations

Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment

2001 • 622 citations

Antipsychotic-Induced Hyperprolactinaemia

2004 • 601 citations

Early intervention in psychosis

1998 • 588 citations

Multiple-Family Groups and Psychoeducation in the Treatment of Schizophrenia

1995 • 547 citations

Prevalence and Risk Factors for Homelessness and Utilization of Mental Health Services Among 10,340 Patients With Serious Mental Illness in a Large Public Mental Health System

2005 • 533 citations

Randomized, Double-Blind Trial of Olanzapine Versus Placebo in Patients Prodromally Symptomatic for Psychosis

2006 • 530 citations

Relapse Prevention in Schizophrenia With New-Generation Antipsychotics: A Systematic Review and Exploratory Meta-Analysis of Randomized, Controlled Trials

2003 • 501 citations

From dopamine to salience to psychosis—linking biology, pharmacology and phenomenology of psychosis

2005 • 494 citations

Schizophrenia, just the facts

1988 • 486 citations

A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia

2008 • 485 citations

Early intervention for psychosis

2011 • 482 citations

MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA

1978 • 464 citations

How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials

2008 • 463 citations

Predictors of Treatment Response From a First Episode of Schizophrenia or Schizoaffective Disorder

1999 • 462 citations

Double-Blind Comparison of First- and Second-Generation Antipsychotics in Early-Onset Schizophrenia and Schizo-affective Disorder: Findings From the Treatment of Early-Onset Schizophrenia Spectrum Disorders (TEOSS) Study

2008 • 455 citations

Time Course and Biologic Correlates of Treatment Response in First-Episode Schizophrenia

1993 • 454 citations

Translating Scientific Opportunity Into Public Health Impact

2009 • 440 citations

Neuroleptic Withdrawal in Schizophrenic Patients

1995 • 436 citations

Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia

2004 • 413 citations

Using Neuroplasticity-Based Auditory Training to Improve Verbal Memory in Schizophrenia

2009 • 409 citations

Psychiatric Symptoms and Quality of Life in Schizophrenia: A Meta-Analysis

2007 • 406 citations

The effects of antipsychotic therapy on serum lipids: a comprehensive review

2004 • 406 citations

Randomized Controlled Trial of Effect of Prescription of Clozapine Versus Other Second-Generation Antipsychotic Drugs in Resistant Schizophrenia

2005 • 406 citations

The Psychosocial Treatment of Schizophrenia: An Update

2001 • 405 citations

Cognitive therapy for psychosis in schizophrenia: an effect size analysis

2001 • 402 citations

Delayed-Onset Hypothesis of Antipsychotic Action

2003 • 401 citations

Cognitive Behavioral Therapy for Schizophrenia: An Empirical Review

2001 • 398 citations

Cognitive Improvement After Treatment With Second-Generation Antipsychotic Medications in First-Episode Schizophrenia

2007 • 392 citations

Improving Employment Outcomes for Persons With Severe Mental Illnesses

2002 • 390 citations

A meta-analysis of controlled research on social skills training for schizophrenia.

2008 • 389 citations

Schizophrenia, “Just the Facts”: What we know in 2008

2008 • 388 citations

Efficacy of Psychological Therapy in Schizophrenia: Conclusions From Meta-analyses

2006 • 386 citations

Dopamine D2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient

2001 • 377 citations

Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study

2006 • 374 citations

A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia

2009 • 367 citations

The effect of cognitive behavioral treatment on the positive symptoms of schizophrenia spectrum disorders: A meta-analysis

2005 • 365 citations

Neuroplasticity of Neocortical Circuits in Schizophrenia

2007 • 362 citations

Evidence of Clozapine’s Effectiveness in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Trials

1999 • 357 citations

Neuroprotective Effects of Cognitive Enhancement Therapy Against Gray Matter Loss in Early Schizophrenia

2010 • 349 citations

Schizophrenia, “just the facts”: What we know in 2008Part 3: Neurobiology

2008 • 348 citations

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 2: Long-term treatment of schizophrenia

2006 • 344 citations

Use of intensive case management to reduce time in hospital in people with severe mental illness: systematic review and meta-regression

2007 • 335 citations

A Review of Cognitive Training in Schizophrenia

2003 • 333 citations

Psychological treatments in schizophrenia: II. Meta-analyses of randomized controlled trials of social skills training and cognitive remediation

2002 • 327 citations

Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia

2008 • 324 citations

The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary

2003 • 321 citations

Cariprazine (RGH-188), a Dopamine D₃ Receptor-Preferring, D₃/D₂ Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile

2010 • 320 citations

Cognitive behavioural therapy for major psychiatric disorder: does it really work? A meta-analytical review of well-controlled trials

2009 • 317 citations

Introduction: Methods, Commentary, and Summary

2004 • 316 citations

Electroconvulsive therapy for schizophrenia

2005 • 315 citations

Removing Obstacles in Neuroscience Drug Discovery: The Future Path for Animal Models

2008 • 312 citations

Cognitive Effects of Antipsychotic Drugs in First-Episode Schizophrenia and Schizophreniform Disorder: A Randomized, Open-Label Clinical Trial (EUFEST)

2009 • 310 citations

A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: opening a closed book

2004 • 309 citations

The Metabolic Effects of Antipsychotic Medications

2006 • 308 citations

Is there evidence that cognitive behaviour therapy is an effective treatment for schizophrenia? A cautious or cautionary tale?

2004 • 300 citations

Effectiveness of psychoeducation for relapse, symptoms, knowledge, adherence and functioning in psychotic disorders: A meta-analysis

2007 • 296 citations

Systematic meta-review of depot antipsychotic drugs for people with schizophrenia

2001 • 296 citations

Outcome of common mental disorders in Harare, Zimbabwe

1998 • 296 citations

Intervention in Individuals at Ultra-High Risk for Psychosis

2009 • 291 citations

Cognitive-behavioural therapy and family intervention for relapse prevention and symptom reduction in psychosis: Randomised controlled trial

2008 • 289 citations

Cognitive Remediation in Schizophrenia

2009 • 289 citations

Important Issues in the Drug Treatment of Schizophrenia

1980 • 286 citations

Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs

1997 • 284 citations

Effects of Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE Study

2007 • 281 citations

Roles of the Akt/GSK-3 and Wnt Signaling Pathways in Schizophrenia and Antipsychotic Drug Action

2009 • 278 citations

Pimavanserin, a Serotonin2A Receptor Inverse Agonist, for the Treatment of Parkinson's Disease Psychosis

2009 • 276 citations

Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia

2008 • 276 citations

Phenothiazines and structurally related drugs

1975 • 274 citations

First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: Systematic review and meta-analysis

2008 • 273 citations

An overview of family interventions and relapse on schizophrenia: meta-analysis of research findings

1994 • 272 citations

Towards a muscarinic hypothesis of schizophrenia

2006 • 269 citations

Psychosocial Treatments to Promote Functional Recovery in Schizophrenia

2009 • 268 citations

World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia

2008 • 268 citations

Psychosocial Treatment for First-Episode Psychosis: A Research Update

2005 • 266 citations

Which comes first: atypical antipsychotic treatment or cardiometabolic risk?

2009 • 258 citations

Three-Year Trials of Personal Therapy Among Schizophrenic Patients Living With or Independent of Family, I: Description of Study and Effects on Relapse Rates

1997 • 258 citations

Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia

2009 • 255 citations

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Acute treatment of schizophrenia

2005 • 251 citations

Toward a Terminology for Functional Recovery in Schizophrenia: Is Functional Remission a Viable Concept?

2009 • 247 citations

Adult Neurogenesis, Mental Health, and Mental Illness: Hope or Hype?: Figure 1.

2008 • 245 citations

Clinical Pharmacokinetics of Atypical Antipsychotics

2007 • 244 citations

Efficacy of Slow Repetitive Transcranial Magnetic Stimulation in the Treatment of Resistant Auditory Hallucinations in Schizophrenia

2007 • 242 citations

The history of clozapine and its emergence in the US market

2007 • 240 citations

Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia

2009 • 235 citations

Preventing the Second Episode: A Systematic Review and Meta-analysis of Psychosocial and Pharmacological Trials in First-Episode psychosis

2009 • 235 citations

The Effectiveness of Assertive Community Treatment for Homeless Populations With Severe Mental Illness: A Meta-Analysis

2007 • 233 citations

Antipsychotic drugs and heart muscle disorder in international pharmacovigilance: data mining study

2001 • 231 citations

A review of the literature on the effectiveness of housing and support, assertive community treatment, and intensive case management interventions for persons with mental illness who have been homeless.

2007 • 229 citations

Benzodiazepines in the treatment of schizophrenia: a review and reappraisal

1991 • 225 citations

Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies

2009 • 223 citations

Influence of antipsychotics on mortality in schizophrenia: Systematic review

2009 • 220 citations

Can Antidepressants Be Used to Treat the Schizophrenia Prodrome?

2007 • 216 citations

Early-Onset Hypothesis of Antipsychotic Drug Action: A Hypothesis Tested, Confirmed and Extended

2005 • 215 citations

Who Benefits From Supported Employment: A Meta-analytic Study

2009 • 212 citations

Effect of second-generation antipsychotics on cognition: current issues and future challenges

2009 • 211 citations

Social skills training with schizophrenics: A meta-analytic evaluation.

1990 • 211 citations

Applicability of a Genetic Signature for Enhanced Iloperidone Efficacy in the Treatment of Schizophrenia

2009 • 205 citations

Neuroleptic Withdrawal in Schizophrenic Patients

1995 • 200 citations

The Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities

2007 • 200 citations

Cognitive Rehabilitation for Schizophrenia and the Putative Role of Motivation and Expectancies

2005 • 198 citations

Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia†Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1).

2009 • 194 citations

The efficacy of lamotrigine in clozapine-resistant schizophrenia: A systematic review and meta-analysis

2009 • 187 citations

Negative symptoms of schizophrenia: a problem that will not go away

2006 • 184 citations

Social skills training with schizophrenics: A meta-analytic evaluation.

1990 • 182 citations

Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia

2009 • 171 citations

Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studies

2005 • 171 citations

Is There a Future for Histone Deacetylase Inhibitors in the Pharmacotherapy of Psychiatric Disorders?

2009 • 170 citations

Molecular Mechanisms of Action and In Vivo Validation of an M4 Muscarinic Acetylcholine Receptor Allosteric Modulator with Potential Antipsychotic Properties

2009 • 161 citations

A Randomized, Placebo-Controlled Study of Memantine as Adjunctive Treatment in Patients with Schizophrenia

2008 • 158 citations

Benzodiazepines for schizophrenia

2012 • 158 citations

A Randomized, Controlled Trial of Computer-Assisted Cognitive Remediation for Schizophrenia

2009 • 154 citations

Unmet Need for Mental Health Care in Schizophrenia: An Overview of Literature and New Data From a First-Admission Study

2009 • 151 citations

The Evolution of Cognitive Behavior Therapy for Schizophrenia: Current Practice and Recent Developments

2009 • 150 citations

EPS Profiles: The Atypical Antipsychotics

2007 • 147 citations

Rehabilitation for Adults with Severe Mental Illness and Substance Use Disorders

1993 • 147 citations

The 'atypicality' of antipsychotics: a concept re-examined and re-defined

2009 • 145 citations

Assertive outreach for frequent users of psychiatric hospitals: A meta-analysis

1995 • 145 citations

Efficacy of atypicalv.typical antipsychotics in the treatment of early psychosis: meta-analysis

2010 • 145 citations

Histamine H₃and H₄receptors as novel drug targets

2009 • 143 citations

The American Psychiatric Press Textbook of Psychopharmacology

1995 • 142 citations

Repetitive Transcranial Magnetic Stimulation for Negative Symptoms of Schizophrenia

2010 • 140 citations

Polypharmacy in schizophrenia

2010 • 139 citations

The case for long‐acting antipsychotic agents in the post‐CATIE era

2007 • 137 citations

Outcomes of public concern in schizophrenia

2007 • 133 citations

Dopamine D₁ receptor ligands: Where are we now and where are we going

2008 • 133 citations

Selecting Paradigms From Cognitive Neuroscience for Translation into Use in Clinical Trials: Proceedings of the Third CNTRICS Meeting

2008 • 132 citations

Time Course for Antipsychotic Treatment Response in First-Episode Schizophrenia

2006 • 130 citations

Frontal leukotomy and related psychosurgical procedures in the era before antipsychotics (1935-1954): a historical overview

1995 • 129 citations

Neuroleptic dysphoria: towards a new synthesis

2004 • 129 citations

Cognitive Function in Schizophrenia— Do Neuroleptics Make a Difference?

1997 • 128 citations

Lurasidone: a new drug in development for schizophrenia

2009 • 128 citations

The Dosing of Atypical Antipsychotics

2005 • 126 citations

Adjunctive psychosocial therapies for the treatment of schizophrenia

2008 • 125 citations

Pharmacogenomics in schizophrenia: the quest for individualized therapy

2002 • 125 citations

Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland

2005 • 120 citations

A Survey of the Practice of Electroconvulsive Therapy in Asia

2010 • 120 citations

Effects of a mutual support group for families of Chinese people with schizophrenia: 18-month follow-up

2006 • 120 citations

GABAA receptors and their associated proteins: Implications in the etiology and treatment of schizophrenia and related disorders

2009 • 117 citations

Defining and Measuring Clinical Effectiveness in the Treatment of Schizophrenia

2005 • 117 citations

COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence.

2010 • 115 citations

The involvement of the NMDA receptor d-serine/glycine site in the pathophysiology and treatment of schizophrenia

2009 • 114 citations

TREATMENT OF SCHIZOPHRENIC REACTIONS WITH PHENOTHIAZINE DERIVATIVES

1960 • 113 citations

Implementing Evidence-Based Practices for People With Schizophrenia

2009 • 112 citations

Time Course for Antipsychotic Treatment Response in First-Episode Schizophrenia

2006 • 112 citations

Chlorpromazine Dose for People With Schizophrenia

2009 • 110 citations

Current status of inverse agonism at serotonin2A (5-HT2A) and 5-HT2C receptors

2008 • 109 citations

Phenothiazines and structurally related drugs

1974 • 104 citations

Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study

2010 • 102 citations

Oil and Water or Oil and Vinegar? Evidence-Based Medicine Meets Recovery

2009 • 100 citations

Neuronal Nicotinic Acetylcholine Receptors - Targets for the Development of Drugs to Treat Cognitive Impairment Associated with Schizophrenia and Alzheimers Disease

2010 • 97 citations

Behavioral Indices in Antipsychotic Drug Discovery

2010 • 96 citations

Blood Dyscrasias Induced by Psychotropic Drugs

2004 • 95 citations

The Role of Phosphodiesterases in Schizophrenia

2008 • 94 citations

Pharmacogenetics in Psychiatry: Are We Ready for Widespread Clinical Use?

2008 • 94 citations

Rationale for the study of early intervention

2001 • 93 citations

Pharmacological Cognitive Enhancement in Schizophrenia

2009 • 93 citations

Glycine transport inhibitors for the treatment of schizophrenia: symptom and disease modification.

2009 • 93 citations

The Hippocampus and Nucleus Accumbens as Potential Therapeutic Targets for Neurosurgical Intervention in Schizophrenia

2009 • 92 citations

Individual psychodynamic psychotherapy and psychoanalysis for schizophrenia and severe mental illness

2001 • 91 citations

Molecular mechanisms underlying glutamatergic dysfunction in schizophrenia: therapeutic implications

2009 • 90 citations

The future (or lack of future) of personalized prescription in psychiatry

2008 • 90 citations

The prevention of schizophrenia

2007 • 90 citations

Early detection and intervention of psychosis. A review

2008 • 89 citations

Antidepressants for the treatment of depression in people with schizophrenia: a systematic review

2003 • 89 citations

Early intervention in patients at ultra high risk of psychosis: benefits and risks

2009 • 88 citations

Neurocognitive Impairment in Schizophrenia and how it Affects Treatment Options

1997 • 88 citations

Effectiveness of second generation antipsychotics: A systematic review of randomized trials

2008 • 85 citations

Building a Better Antipsychotic: Receptor Targets for the Treatment of Multiple Symptom Dimensions of Schizophrenia

2008 • 83 citations

The Combined Use of Electroconvulsive Therapy and Antipsychotics in Patients With Schizophrenia

2005 • 81 citations

Efficacy and effectiveness of individual family intervention on social and clinical functioning and family burden in severe schizophrenia: a 2-year randomized controlled study

2009 • 79 citations

Early intervention in psychotic disorders: faith before facts?

2009 • 75 citations

Progress in Defining Optimal Treatment Outcome in Schizophrenia

2009 • 75 citations

Cognitive remediation for schizophrenia: it is even more complicated

2009 • 74 citations

Antipsychotics in early onset Schizophrenia

2006 • 73 citations

Translating the basic and clinical cognitive neuroscience of schizophrenia to drug development and clinical trials of antipsychotic medications

2001 • 72 citations

Prospective comparison of course of disability in antipsychotic‐treated and untreated schizophrenia patients

2008 • 72 citations

Strategies for Maximizing Clinical Effectiveness in the Treatment of Schizophrenia

2006 • 72 citations

Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia

2009 • 71 citations

Trajectories and Antecedents of Treatment Response Over Time in Early-Episode Psychosis

2008 • 71 citations

5-HT6 Receptor Antagonists as Potential Therapeutics for Cognitive Impairment

2010 • 70 citations

Citalopram Augmentation for Subsyndromal Symptoms of Depression in Middle-Aged and Older Outpatients With Schizophrenia and Schizoaffective Disorder

2008 • 69 citations

Systematic Overview of Cochrane Reviews for Anticholinergic Effects of Antipsychotic Drugs

2009 • 69 citations

Tolcapone Effects on Gating, Working Memory, and Mood Interact with the Synonymous Catechol-O-methyltransferase rs4818C/G Polymorphism

2009 • 68 citations

Life skills programmes for chronic mental illnesses

2008 • 68 citations

Antipsychotic Drugs for First-Episode Schizophrenia

2009 • 67 citations

Delineating disability, labour force participation and employment restrictions among persons with psychosis

2004 • 66 citations

Valproate as an adjunct to antipsychotics for schizophrenia: a systematic review of randomized trials

2004 • 65 citations

AC-260584, an orally bioavailable M1 muscarinic receptor allosteric agonist, improves cognitive performance in an animal model

2009 • 64 citations

Antipsychotic-Like Properties of 5-α-Reductase Inhibitors

2008 • 63 citations

Abstracts

2004 • 62 citations

Lithium for schizophrenia revisited: a systematic review and meta-analysis of randomized controlled trials.

2004 • 62 citations

Antipsychotic Drug Treatment in First-Episode Psychosis

2010 • 61 citations

Potential antipsychotic properties of central cannabinoid (CB₁) receptor antagonists

2010 • 61 citations

Pharmacotherapy of schizophrenia with comorbid substance use disorder — Reviewing the evidence and clinical recommendations

2008 • 61 citations

Metabotropic glutamate mGlu1 receptor stimulation and blockade: Therapeutic opportunities in psychiatric illness

2010 • 60 citations

Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors

2010 • 60 citations

Review Do atypical antipsychotic medications favorably alter the long-term course of schizophrenia?

1998 • 58 citations

The American Psychiatric Press Textbook of Psychopharmacology

1995 • 57 citations

Combined Use of Electroconvulsive Therapy and Antipsychotics in Schizophrenia: the Indian Evidence. A Review and a Meta-analysis

2006 • 57 citations

Dose Response and Atypical Antipsychotics in Schizophrenia

2004 • 57 citations

Lithium for Schizophrenia Revisited

2004 • 56 citations

The action of neuroleptic drugs

1985 • 54 citations

Emerging Opportunities for Antipsychotic Drug Discovery in the Postgenomic Era

2008 • 52 citations

Haloperidol Dose When Used as Active Comparator in Randomized Controlled Trials With Atypical Antipsychotics in Schizophrenia

2006 • 51 citations

The Promise and Reality of Pharmacogenetics in Psychiatry

2010 • 50 citations

Schizophrenia endophenotypes as treatment targets

2007 • 49 citations

Positive and negative symptoms covary during clozapine treatment in schizophrenia

1993 • 49 citations

Shared Decision Making in Antipsychotic Management

2008 • 48 citations

Typical and Atypical Antipsychotics – The Misleading Dichotomy

2008 • 46 citations

Risk of Extrapyramidal Syndrome in Schizophrenic Patients Treated with Antipsychotics: A Population-based Study

2007 • 46 citations

Pregnenolone, Dehydroepiandrosterone, and Schizophrenia: Alterations and Clinical Trials

2010 • 45 citations

Early- and Delayed Antipsychotic Response and Prediction of Outcome in 528 Severely Impaired Patients with Schizophrenia Treated with Amisulpride

2009 • 44 citations

Differences in mortality and suicidal behaviour between treated and never-treated people with schizophrenia in rural China

2009 • 43 citations

Quality assessment and comparison of evidence for electroconvulsive therapy and repetitive transcranial magnetic stimulation for schizophrenia: A systematic meta-review

2010 • 42 citations

The Action of Neuroleptic Drugs

1966 • 42 citations

Epigenetic Therapeutic Strategies for the Treatment of Neuropsychiatric Disorders

2008 • 42 citations

The impact of pharmacogenetics on the development and use of antipsychotic drugs

2007 • 42 citations

Carbamazepine Augmentation for Schizophrenia

2002 • 42 citations

Management of Patients Presenting with Acute Psychotic Episodes of Schizophrenia

2009 • 40 citations

Covariance of positive and negative symptoms during neuroleptic treatment in schizophrenia: A replication

1993 • 40 citations

Heterogeneity of Treatment Effects in Schizophrenia

2007 • 38 citations

Comparing Acute Toxicity of First- and Second-Generation Antipsychotic Drugs

2009 • 38 citations

Considering schizophrenia from a prevention perspective

2004 • 37 citations

The importance of dosage in antipsychotic drug administration ? A review of dose-response studies

1973 • 37 citations

Preventing Clinical Deterioration in the Course of Schizophrenia: The Potential for Neuroprotection

2006 • 35 citations

Do antipsychotics limit disability in schizophrenia? A naturalistic comparative study in the community

2010 • 35 citations

BL-1020: A novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia

2008 • 33 citations

A meta-analysis of profile and time-course of symptom change in acute schizophrenia treated with atypical antipsychotics

2005 • 33 citations

Indicators of Conformance With Guidelines of Schizophrenia Treatment in Mental Health Services

2008 • 32 citations

Revisiting the relapse predictive validity of prodromal symptoms in schizophrenia

2007 • 31 citations

Intervention in the at-risk state to prevent transition to psychosis

2009 • 30 citations

Therapeutic Utility of NK3 Receptor Antagonists for the Treatment of Schizophrenia

2009 • 29 citations

Combination Therapy in the Treatment of Schizophrenia

2010 • 29 citations

Antipsychotic Medication: The Potential Role of 5-HT1A Receptor Agonism

2010 • 26 citations

The Concept of Population Prevention: Application to Schizophrenia

2003 • 26 citations

The intersection of pharmacology, imaging, and genetics in the development of personalized medicine

2009 • 26 citations

Repetitive transcranial magnetic stimulation for refractory symptoms in schizophrenia

2010 • 26 citations

HTS and Rational Drug Design to Generate a Class of 5‐HT_2C‐Selective Ligands for Possible Use in Schizophrenia.

2010 • 26 citations

Treating Schizophrenia: Novel Targets for the Cholinergic System

2010 • 25 citations

Cardiovascular disease and diabetes in people with severe mental illness

2009 • 24 citations

A NEW TREATMENT OF SCHIZOPHRENIA

1937 • 24 citations

Indicators of Conformance With Guidelines of Schizophrenia Treatment in Mental Health Services

2008 • 24 citations

Recent Patents on Positive Allosteric Modulators of the Metabotropic Glutamate 5 Receptor as a Potential Treatment for Schizophrenia

2009 • 23 citations

Maintenance antipsychotic drugs do prevent relapse: A reply to Tobias and MacDonald.

1976 • 23 citations

Classic Antipsychotic Medications

2009 • 23 citations

Novel consortium to address shortfall in innovative medicines for psychiatric disorders

2009 • 23 citations

Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis

2008 • 20 citations

Does catatonic schizophrenia improve faster with electroconvulsive therapy than other subtypes of schizophrenia?

2009 • 19 citations

Effects of TRK-820, a selective kappa opioid receptor agonist, on rat schizophrenia models

2009 • 19 citations

Pharmacogenetic of response efficacy to antipsychotics in schizophrenia: pharmacodynamic aspects. Review and implications for clinical research

2009 • 19 citations

Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients

2010 • 18 citations

The Application of PET Technique for the Development and Evaluation of Novel Antipsychotics

2009 • 17 citations

WS-50030 [7-{4-[3-(1H-inden-3-yl)propyl]piperazin-1-yl}-1,3-benzoxazol-2(3H)-one]: A Novel Dopamine D₂ Receptor Partial Agonist/Serotonin Reuptake Inhibitor with Preclinical Antipsychotic-Like and Antidepressant-Like Activity

2009 • 14 citations

The dopamine D2 receptor partial agonist aplindore improves motor deficits in MPTP-treated common marmosets alone and combined with l-dopa

2009 • 14 citations

Comparison of the efficacy and acceptability of atypical antipsychotic drugs: a meta-analysis of randomized, placebo-controlled trials.

1999 • 14 citations

Drug-responsive symptoms during early neuroleptic treatment

1992 • 13 citations

meta-regression analysis schizophrenia: systematic overview and Atypical antipsychotics in the treatment of

2006 • 12 citations

The audacity of proteomics: a chance to overcome current challenges in schizophrenia research

2009 • 10 citations

Use of biomarkers in the discovery of novel anti-schizophrenia drugs

2009 • 10 citations

Are Second Generation Antipsychotics a Distinct Class?

2008 • 10 citations

Clinical decision‐making during 5 years of antipsychotic treatment

2007 • 10 citations

Evolution of Antipsychotic Intervention in the Schizophrenic Psychosis

2006 • 9 citations

SOURCES OF UNCERTAINTY IN STUDIES OF DRUGS AFFECTING MOOD, MENTATION OR ACTIVITY

1959 • 8 citations

Potential microbial origins of schizophrenia and their treatments

2009 • 7 citations

Drug Discovery in Psychiatric Illness: Mining for Gold

2009 • 6 citations

Potential microbial origins of schizophrenia and their treatments

2009 • 5 citations

EVALUATION OF DRUG TREATMENTS IN PSYCHIATRY.

1964 • 5 citations

Cognitive Behavior Therapy for Schizophrenia

2008 • 3 citations

First- and Second-Generation Antipsychotics and the Concept of “Atypicality”

2009 • 3 citations

New generation versus conventional antipsychotics

2003 • 2 citations